We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+13.6%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$1.16B
AUM Growth
+$73.7M
Cap. Flow
+$24.1M
Cap. Flow %
2.08%
Top 10 Hldgs %
27.51%
Holding
208
New
17
Increased
35
Reduced
30
Closed
120

Sector Composition

Rank Sector Weight
1 Healthcare 90.35%
2 Industrials 4.01%
3 Technology 0.1%
4 Energy 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIO icon
101
Bio-Rad Laboratories Class A
BIO
$8.96B
-3,200
Closed -$1.45M
BKD icon
102
Brookdale Senior Living
BKD
$3.43B
-28,100
Closed -$83K
BLUE
103
DELISTED
bluebird bio
BLUE
-764
Closed -$604K
BRKR icon
104
Bruker
BRKR
$9.79B
-15,900
Closed -$647K
CAH icon
105
Cardinal Health
CAH
$55.2B
-45,500
Closed -$2.38M
CHE icon
106
Chemed
CHE
$7.07B
-2,300
Closed -$1.04M
CNMD icon
107
CONMED
CNMD
$1.55B
-4,100
Closed -$295K
COLL icon
108
Collegium Pharmaceutical
COLL
$1.15B
-654,521
Closed -$11.5M
COO icon
109
Cooper Companies
COO
$14.5B
-30,000
Closed -$2.13M
CORT icon
110
Corcept Therapeutics
CORT
$12.2B
-14,700
Closed -$247K
CRL icon
111
Charles River Laboratories
CRL
$11.1B
-7,500
Closed -$1.31M
CRSP icon
112
CRISPR Therapeutics
CRSP
$4.88B
-114,400
Closed -$8.41M
DGX icon
113
Quest Diagnostics
DGX
$25.6B
-20,600
Closed -$2.35M
DNLI icon
114
Denali Therapeutics
DNLI
$3.67B
-9,600
Closed -$232K
DVA icon
115
DaVita
DVA
$15B
-12,700
Closed -$1M
EDIT icon
116
Editas Medicine
EDIT
$407M
-8,500
Closed -$251K
EHC icon
117
Encompass Health
EHC
$11.2B
-18,981
Closed -$935K
ELAN icon
118
Elanco Animal Health
ELAN
$12.8B
-61,600
Closed -$1.32M
ENSG icon
119
The Ensign Group
ENSG
$10.3B
-7,800
Closed -$326K
ESPR
120
DELISTED
Esperion Therapeutics
ESPR
-3,900
Closed -$200K
EXAS
121
DELISTED
Exact Sciences
EXAS
-22,900
Closed -$1.99M
GKOS icon
122
Glaukos
GKOS
$10.1B
-6,400
Closed -$246K
GMED icon
123
Globus Medical
GMED
$11.1B
-11,400
Closed -$544K
HAE icon
124
Haemonetics
HAE
$3.94B
-7,600
Closed -$681K
HALO icon
125
Halozyme
HALO
$9.76B
-20,800
Closed -$558K

Similar funds

Sectoral Asset Management's Q3 2020 Portfolio in Review

As of Q3 2020, Sectoral Asset Management held 208 positions worth $1.16B, up 6.8% from $1.09B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Sectoral Asset Management's Q3 2020 filing shows 17 new, 35 increased, 30 reduced and 120 closed positions. Its largest new stake was Arcus Biosciences: 922,800 shares worth $15.8M. The largest sale was HILL-ROM HOLDINGS, INC., an estimated $27.4M.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, up from 86% a quarter earlier, followed by Industrials and Technology.

  • Sectoral Asset Management's largest Q3 2020 buy was Arcus Biosciences: 922,800 shares worth $15.8M.
  • Sectoral Asset Management added most to Labcorp in Q3 2020, an estimated $29.5M increase.
  • Sectoral Asset Management's biggest Q3 2020 reduction was Change Healthcare Inc. Common Stock, cutting an estimated $17.1M.
  • Sectoral Asset Management fully exited HILL-ROM HOLDINGS, INC. in Q3 2020, selling an estimated $27.4M.
  • Sectoral Asset Management's ten largest holdings make up 28% of its $1.16B portfolio in Q3 2020.
  • Sectoral Asset Management opened 17 new positions and closed 120 in Q3 2020.
  • Sectoral Asset Management's portfolio value rose 6.8% quarter-over-quarter to $1.16B.

Based on Sectoral Asset Management's 13F filing for Q3 2020, filed 13 Nov 2020.